Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Irritable Bowel Syndrome (IBS) using a specific questionnaire from the World Global Gastroenterology Organization
- Your IBS symptoms are rated at 175 points or higher on a standard IBS symptom severity scoring system (confirm with trial site)
Who may not be able to join:
- You are currently taking probiotic products (such as certain yogurts, supplements, or drinks with live cultures), or have taken them in the last 3 months
- You are currently taking antibiotics, or have taken them in the last 3 months
- You have another serious illness, such as cancer, poorly controlled high blood pressure or diabetes, liver, kidney or heart problems, serious neurological or mental health conditions, breathing conditions like asthma or COPD, or a thyroid disorder
- You have a chronic bowel condition other than IBS, such as inflammatory bowel disease, gastroenteritis, stomach or bowel cancer, or coeliac disease
- You are pregnant, breastfeeding, or planning to become pregnant in the next 9 months
- You have been diagnosed with lactose intolerance
- You have used medication to help with gut movement or fibre supplements within 2 weeks before the trial starts
- You are taking blood-thinning (anti-coagulant) medication
- You have taken part in another clinical trial within the last 3 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jacek Piatek, Prof. Dr., The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz
Phone: +48883389788
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Severity of IBS using the IBS-Severity Scoring System (IBS-SSS); Changes of IBS severity using the IBS Global Improvement Scale (IBS-GIS); Changes in adequate relief of IBS-symptoms (IBS-AR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.